Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA-KIDNEY.
Nangaku M, Herrington WG, Goto S, Maruyama S, Kashihara N, Ueki K, Wada J, Watada H, Nakashima E, Lee R, Massey D, Mayne KJ, Tomita A, Haynes R, Hauske SJ, Kadowaki T.
Nangaku M, et al. Among authors: tomita a.
Clin Exp Nephrol. 2024 Apr 20. doi: 10.1007/s10157-024-02489-4. Online ahead of print.
Clin Exp Nephrol. 2024.
PMID: 38643286